Sequoia Financial Advisors, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1599900 Akron, OH

Position in ALNY

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$1,508,767

-$166,134 QoQ

Shares Held

4,560

+8.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Sequoia Financial Advisors, LLC holds $24,441,881 across 36 Biotechnology names. ALNY ranks #5 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	14,898	$6,652,552
2	REGN	Regeneron Pharmaceuticals, Inc.	3,189	$2,463,948
3	FTRE	Fortrea Holdings Inc.	175,917	$1,657,138
4	INCY	Incyte Corp	16,377	$1,541,403
5	ALNY	Alnylam Pharmaceuticals, Inc. This page	4,560	$1,508,767
6	ARGX	Argenx SE	1,961	$1,432,020
7	JAZZ	Jazz Pharmaceuticals plc	4,138	$782,288
8	RPRX	Royalty Pharma plc	15,670	$751,689

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,508,767	4,560	+8.3%	Shares	Sole	2026-04-30
2025-12-31	$1,674,901	4,212	-2.2%	Shares	Sole	2026-02-03
2025-09-30	$1,963,536	4,306	+9.9%	Shares	Sole	2025-10-29
2025-06-30	$1,277,294	3,917	+15.4%	Shares	Sole	2025-07-25
2025-03-31	$916,717	3,395	+3.0%	Shares	Sole	2025-04-23
2024-12-31	$775,581	3,296	+5.3%	Shares	Sole	2025-08-08
2024-09-30	$860,568	3,129	-5.4%	Shares	Sole	2024-10-21
2024-06-30	$803,844	3,308	+13.7%	Shares	Sole	2024-07-15
2024-03-31	$434,899	2,910	-62.3%	Shares	Sole	2024-04-30
2023-12-31	$1,476,536	7,714	+175.2%	Shares	Sole	2024-01-26
2023-09-30	$496,411	2,803	-5.0%	Shares	Sole	2023-11-08
2023-06-30	$560,512	2,951	+216.0%	Shares	Sole	2023-08-08
2022-12-31	$221,965	934	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.